## Abstract In this paper, we describe the structure‐based design, synthesis, and biological evaluation of cytosine derivatives and analogues that inhibit IspF, an enzyme in the non‐mevalonate pathway of isoprenoid biosynthesis. This pathway is responsible for the biosynthesis of the C~5~ precursor
The non-mevalonate pathway of isoprenoids: genes, enzymes and intermediates
✍ Scribed by Felix Rohdich; Klaus Kis; Adelbert Bacher; Wolfgang Eisenreich
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 81 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1367-5931
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The enzymes of the non‐mevalonate pathway for isoprenoid biosynthesis are attractive targets for the development of novel drugs against malaria and tuberculosis. This pathway is used exclusively by the corresponding pathogens, but not by humans. A series of water‐soluble, cytidine‐based
Optically pure 2-C-methyl-d-erythritol 4-phosphate, a key intermediate in the mevalonate-independent route for isoprenoid biosynthesis, is conveniently synthesized from 1,2-O-isopropylidene-a-d-xylofuranose, including the possibility of radiolabeling of this substrate.